1MUECK A O,SEEGER H,WALLWIENER D.Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules[].Experimental and Clinical Endocrinology.2001
2DOBRUCKI L W,KALINOWSKI L,DOBRUCKI I T,et al.Statin-stimulated nitric oxide release from endothelium[].Medical Science Monitor.2001
3RIDKER P M,RIFAI N,PFEFFER M A,et al.For the chelesterol and recurrent events (CEAR) investigation, inflammation,pravastain and the risk of coronary events after myocardio infarction in patients with average cholesterol reduction[].Circulation.1988
4ORTEGO M,BUSTOS C,HERNANDEZ-PRESA M A,et al.Atorvastatin reduces NFB activitation and chemokine expression in vascular smooth muscle cells and mononuclear cells[].Atherosclerosis.1999
5SHEPHERD J,COBBE S M,FORDI,et al.Prevention of coronary heart disease with pravaststin in men with hypercholesterol[].The New England Journal of Medicine.1995
6CORSINI A.Fluvastatin: effects beyond cholesterol lowering[].Journal of Cardiovascular Pharmacology.2000
7LAUFS U,GERTZ K,HUANG P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice[].Stroke.2000
8WATERS D D,AZAR R R.Should intensive cholesterol lowering play a role in the management of acute coronary syndromes[].The American Journal of Cardiology.2000
5Waters DD, Ku 1. Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation [ J ]. J Am Coil Cardiol, 2009, 54 (15) : 1434 -1437.
6Khera AV, Wolfe ML, Cannon CP, et al. On -statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy - thrombolysis in myocardial infarction 22 [PROVE IT -TIMI 22] study) [J]. Am J Cardiol, 2010, 106 (4): 451-456.
7Wiviott SD, De Lemos JA, Connon CP, et al. A tale of two trials: a comparison of the post - acute coronary syndromelipid - lowering trials A to Z and PROVE ITTI M1 22 [J]. Circulation, 2006, 113 ( 11 ) : 1406 - 1414.
9Scott M. Grundy,James I. Cleeman,C. Noel Bairey Merz,H. Bryan Brewer,Luther T. Clark,Donald B. Hunninghake,Richard C. Pasternak,Sidney C. Smith,Neil J. Stone.Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines[J]. Circulation: Journal of the American Heart Association . 2004 (2)
